173 related articles for article (PubMed ID: 26908550)
1. Anatomic Derkay Score Is Associated with Voice Handicap in Laryngeal Papillomatosis in Adults.
Kupfer RA; Çadalli Tatar E; Barry JO; Allen CT; Merati AL
Otolaryngol Head Neck Surg; 2016 Apr; 154(4):689-92. PubMed ID: 26908550
[TBL] [Abstract][Full Text] [Related]
2. Photoangiolytic laser treatment of recurrent respiratory papillomatosis: a scaled assessment.
Kuet ML; Pitman MJ
J Voice; 2013 Jan; 27(1):124-8. PubMed ID: 23102824
[TBL] [Abstract][Full Text] [Related]
3. Voice and quality of life in patients with recurrent respiratory papillomatosis in a northern Sweden cohort.
Loizou C; Laurell G; Lindquist D; Olofsson K
Acta Otolaryngol; 2014 Apr; 134(4):401-6. PubMed ID: 24433057
[TBL] [Abstract][Full Text] [Related]
4. Use of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children.
Rogers DJ; Ojha S; Maurer R; Hartnick CJ
JAMA Otolaryngol Head Neck Surg; 2013 May; 139(5):496-501. PubMed ID: 23681032
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of diabetes mellitus and its impact on disease severity in adult recurrent respiratory papillomatosis.
Lee CJ; Allen CT; Merati AL
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):603-7. PubMed ID: 23851281
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Voice Outcomes Following Serial Potassium Titanyl Phosphate Laser Procedures for Recurrent Respiratory Papillomatosis.
Hung WC; Lo WC; Fang KM; Cheng PW; Wang CT
Ann Otol Rhinol Laryngol; 2021 Apr; 130(4):363-369. PubMed ID: 32847376
[TBL] [Abstract][Full Text] [Related]
7. Office-Based vs Traditional Operating Room Management of Recurrent Respiratory Papillomatosis: Impact of Patient Characteristics and Disease Severity.
Tatar EÇ; Kupfer RA; Barry JY; Allen CT; Merati AL
JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):55-59. PubMed ID: 27658005
[TBL] [Abstract][Full Text] [Related]
8. Surgery and Adjuvant Therapy Improve Derkay Scores in Adult and Pediatric Respiratory Papillomatosis.
Hock K; Kennedy A; Howell R; Friedman A; de Alarcon A; Khosla S
Laryngoscope; 2022 Dec; 132(12):2420-2426. PubMed ID: 35119691
[TBL] [Abstract][Full Text] [Related]
9. Voice improvement in patients with recurrent respiratory papillomatosis after combined treatment with cidofovir and CO
Jackowska J; Wojnowski W; Hashimoto A; Małaczyńska B; Piersiala K; Świdziński P; Wiskirska-Woźnica B; Wierzbicka M
Lasers Med Sci; 2019 Sep; 34(7):1433-1440. PubMed ID: 30762194
[TBL] [Abstract][Full Text] [Related]
10. Correlation of the Voice Handicap Index-10 (VHI-10) and Voice-Related Quality of Life (V-RQOL) in patients with dysphonia.
Romak JJ; Orbelo DM; Maragos NE; Ekbom DC
J Voice; 2014 Mar; 28(2):237-40. PubMed ID: 24321582
[TBL] [Abstract][Full Text] [Related]
11. Correlation of the Voice Handicap Index (VHI) and the Voice-Related Quality of Life Measure (V-RQOL).
Portone CR; Hapner ER; McGregor L; Otto K; Johns MM
J Voice; 2007 Nov; 21(6):723-7. PubMed ID: 16887328
[TBL] [Abstract][Full Text] [Related]
12. Multidimensional vocal assessment after laser treatment for recurrent respiratory papillomatosis.
Kono T; Yabe H; Uno K; Saito K; Ogawa K
Laryngoscope; 2017 Mar; 127(3):679-684. PubMed ID: 27515839
[TBL] [Abstract][Full Text] [Related]
13. Quality of life of patients with recurrent respiratory papillomatosis.
San Giorgi MRM; Aaltonen LM; Rihkanen H; Tjon Pian Gi REA; van der Laan BFAM; Hoekstra-Weebers JEHM; Dikkers FG
Laryngoscope; 2017 Aug; 127(8):1826-1831. PubMed ID: 27861969
[TBL] [Abstract][Full Text] [Related]
14. High-dose sublesional bevacizumab (avastin) for pediatric recurrent respiratory papillomatosis.
Sidell DR; Nassar M; Cotton RT; Zeitels SM; de Alarcon A
Ann Otol Rhinol Laryngol; 2014 Mar; 123(3):214-21. PubMed ID: 24633948
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the Effect of Recurrent Respiratory Papillomatosis on Work Productivity.
Chung TK; Hu A; Sardesai MG; Wilcox H; Jiang L; Meyer TK
Ann Otol Rhinol Laryngol; 2022 Jul; 131(7):709-714. PubMed ID: 34416839
[TBL] [Abstract][Full Text] [Related]
16. Recurrent respiratory papillomatosis disease course in immunosuppressed populations.
Erickson EL; Freeman TE; Sun S; Koch B; Allen DZ; Sethia R; deSilva B; Matrka L
J Laryngol Otol; 2024 May; 138(5):576-580. PubMed ID: 37877153
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study.
Ablanedo-Terrazas Y; Estrada-Camacho O; Alvarado-de la Barrera C; Ramírez-García A; Tona-Acedo G; Bross-Soriano D; Schimelmitz-Idi J
Acta Otorrinolaringol Esp (Engl Ed); 2022; 73(2):82-88. PubMed ID: 35397828
[TBL] [Abstract][Full Text] [Related]
18. Patient reported voice outcome in recurrent respiratory papillomatosis.
van Nieuwenhuizen AJ; Rinkel RN; de Bree R; Leemans CR; Verdonck-de Leeuw IM
Laryngoscope; 2010 Jan; 120(1):188-92. PubMed ID: 19877192
[TBL] [Abstract][Full Text] [Related]
19. Smoking and Carcinoma Trends in Recurrent Respiratory Papillomatosis Patients.
Freeman T; Erickson E; Koch B; Young T; Allen D; Kim B; deSilva B; Matrka L
Ann Otol Rhinol Laryngol; 2023 Nov; 132(11):1380-1385. PubMed ID: 36879422
[TBL] [Abstract][Full Text] [Related]
20. Voice-related Quality of Life in laryngectomees: assessment using the VHI and V-RQOL symptom scales.
Kazi R; De Cordova J; Singh A; Venkitaraman R; Nutting CM; Clarke P; Rhys-Evans P; Harrington KJ
J Voice; 2007 Nov; 21(6):728-34. PubMed ID: 16815670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
